Conduent Incorporated announced the launch of the IntelliHealth module for healthcare provider engagement. This new module is an end-to-end solution to help pharma organizations improve access to, and increase engagement with, healthcare professionals to drive focused pharmaceutical sales and marketing. IntelliHealth enables pharma organizations to power faster and more effective product commercialization with advanced analytics, omnichannel communication and experienced sales professionals and medical science liaisons.

The robust platform delivers highly flexible hybrid engagement models that enable pharma organizations to reduce risk, manage costs and gain competitive advantages while driving ROI across the full life cycle of a drug therapy. Pharma organizations are quickly adapting to the new normal where face-to-face contact to educate healthcare providers (HCPs) on established and emerging drug therapies has given way to remote interactions. The HCP now dictates when interactions occur across a variety of communications channels.

IntelliHealth is built on modular architecture and application programming interfaces that integrate with other third-party services to drive omnichannel engagement from drug launch to maturity with measurable outcomes across the product lifecycle. The next-generation technology is matched with the company's proven experience in delivering emergent campaigns, via remote and digital engagement, to create a seamless experience for HCPs.